Sanofi (SNY.US) halts STAT6 program; Nurix (NRIX.US) falls over 30% in premarket trading! Milestone payments and royalties both fall through.

Zhitong Finance APP has learned that Nurix Therapeutics (NRIX.US) extended its previous after-hours decline in pre-market trading on Wednesday after announcing that its partner Sanofi (SNY.US) decided to discontinue research on an experimental inflammatory disease therapy. As of press time, Nurix fell 32.96% to $17.31.